Drugs for Neglected Diseases initiative (DNDi) / dndi_transparency-activities
Pandemic preparedness
CH-FDJP-CHE110141200-81
EUR 48.31mdeclared budget
EUR 45.34mdisbursed and spent, 1,242 of 1,242 transactions
Implementationstatus
31 Dec 2028planned end
Budget over time
- Reporting organisation
- Drugs for Neglected Diseases initiative (DNDi)
- Start
- 01 Jan 2020 (planned)
- Countries
- —
- Sectors
- Health policy and administrative management (12110) 10%; Medical services (12191) 10%; Basic health infrastructure (12230) 10%; Infectious disease control (12250) 50%; Health education (12261) 15%; Health personnel development (12281) 5%; 121 · OECD DAC 3-digit 20%; 122 · OECD DAC 3-digit 80%; 3 · SDG goal 100%; 3.3 · SDG target 100%; 3.3.5 Number of people requiring interventions against neglected tropical diseases · SDG indicator 100%
- Funded by
- Drugs for Neglected Diseases initiative
- Participating
- Drugs for Neglected Diseases initiative (funding)
- Versions seen
- 2 since 26 Sept 2026 · last checked 2026-10-03 02:26 UTC
Changes
- 2026-10-03Budget changed+1 more
Budget EUR 44.49m → EUR 48.31m (+8.6%)
- Transactions added: 109 transactions added, EUR 5.36m
Pandemic preparedness · compare 0fbd0f94 → 795bcf10
Budgets
| Period | Type | Value | Record |
|---|---|---|---|
| 2021-01-01 → 2021-12-31 | revised, indicative | EUR 15.78m | new since 02 Oct 2026 |
| 2022-01-01 → 2022-12-31 | revised, indicative | EUR 17.27m | new since 02 Oct 2026 |
| 2023-01-01 → 2023-12-31 | revised, indicative | EUR 5.30m | new since 02 Oct 2026 |
| 2024-01-01 → 2024-12-31 | revised, indicative | EUR 6.14m | new since 02 Oct 2026 |
| 2025-01-01 → 2025-12-31 | revised, indicative | EUR 3.82m | new since 02 Oct 2026 |
| 2021-01-01 → 2021-12-31 | original | EUR 15.78m | superseded, last seen 02 Oct 2026 |
| 2022-01-01 → 2022-12-31 | original | EUR 17.27m | superseded, last seen 02 Oct 2026 |
| 2023-01-01 → 2023-12-31 | original | EUR 5.30m | superseded, last seen 02 Oct 2026 |
| 2024-01-01 → 2024-12-31 | original | EUR 6.14m | superseded, last seen 02 Oct 2026 |
Transactions
| Date | Type | Value | To | Note | Record |
|---|---|---|---|---|---|
| 2021-01-31 | Expenditure | EUR -2,053 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2101-1-BR | |
| 2021-01-31 | Expenditure | EUR -49k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2101-2-BR-XM-DAC-30010 | |
| 2021-01-31 | Expenditure | EUR 1,268 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2101-3-BR | |
| 2021-01-31 | Expenditure | EUR 45k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2101-1-CD | |
| 2021-01-31 | Expenditure | EUR 916 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2101-2-CD | |
| 2021-01-31 | Expenditure | EUR 96 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2101-1-CH | |
| 2021-01-31 | Expenditure | EUR 116k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2101-2-CH | |
| 2021-01-31 | Expenditure | EUR 14k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2101-3-CH-GB-GOV-1 | |
| 2021-01-31 | Expenditure | EUR 227k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2101-4-CH-XM-DAC-30010 | |
| 2021-01-31 | Expenditure | EUR 32k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2101-5-CH | |
| 2021-01-31 | Expenditure | EUR 13k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2101-1-FR | |
| 2021-01-31 | Expenditure | EUR 52k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2101-2-FR-XM-DAC-30010 | |
| 2021-01-31 | Expenditure | EUR 7,805 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2101-1-GB | |
| 2021-01-31 | Expenditure | EUR 3,676 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2101-2-GB-GB-GOV-1 | |
| 2021-01-31 | Expenditure | EUR 46k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2101-3-GB-XM-DAC-30010 | |
| 2021-01-31 | Expenditure | EUR 179k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2101-4-GB | |
| 2021-01-31 | Expenditure | EUR 245 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2101-1-IN | |
| 2021-01-31 | Expenditure | EUR 8,718 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2101-2-IN-GB-GOV-1 | |
| 2021-01-31 | Expenditure | EUR 38k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2101-3-IN-XM-DAC-30010 | |
| 2021-01-31 | Expenditure | EUR 9,021 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2101-1-KE | |
| 2021-01-31 | Expenditure | EUR 4,048 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2101-2-KE-XM-DAC-30010 | |
| 2021-01-31 | Expenditure | EUR 19k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2101-1-US | |
| 2021-01-31 | Expenditure | EUR 36 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2101-2-US | |
| 2021-01-31 | Expenditure | EUR 292k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2101-3-US-GB-GOV-1 | |
| 2021-01-31 | Expenditure | EUR 542 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2101-4-US-XM-DAC-30010 | |
| 2021-02-28 | Expenditure | EUR 8,516 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2102-1-AU | |
| 2021-02-28 | Expenditure | EUR 566 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2102-1-BR | |
| 2021-02-28 | Expenditure | EUR 7,830 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2102-2-BR-XM-DAC-30010 | |
| 2021-02-28 | Expenditure | EUR 25k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2102-1-CD | |
| 2021-02-28 | Expenditure | EUR 86k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2102-1-CH | |
| 2021-02-28 | Expenditure | EUR 4,821 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2102-2-CH-GB-GOV-1 | |
| 2021-02-28 | Expenditure | EUR 93k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2102-3-CH-XM-DAC-30010 | |
| 2021-02-28 | Expenditure | EUR 27k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2102-4-CH | |
| 2021-02-28 | Expenditure | EUR 20k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2102-1-CN | |
| 2021-02-28 | Expenditure | EUR 994 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2102-1-CO | |
| 2021-02-28 | Expenditure | EUR 4,845 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2102-1-FR | |
| 2021-02-28 | Expenditure | EUR 725 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2102-2-FR | |
| 2021-02-28 | Expenditure | EUR 2,758 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2102-3-FR-XM-DAC-30010 | |
| 2021-02-28 | Expenditure | EUR 107k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2102-4-FR | |
| 2021-02-28 | Expenditure | EUR 35k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2102-1-IN | |
| 2021-02-28 | Expenditure | EUR 179 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2102-2-IN-XM-DAC-30010 | |
| 2021-02-28 | Expenditure | EUR 6,926 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2102-1-KE | |
| 2021-02-28 | Expenditure | EUR 1,377 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2102-2-KE-XM-DAC-30010 | |
| 2021-02-28 | Expenditure | EUR 3,738 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2102-1-US | |
| 2021-02-28 | Expenditure | EUR 29k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2102-2-US-XM-DAC-30010 | |
| 2021-02-28 | Expenditure | EUR 87k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2102-3-US | |
| 2021-03-31 | Expenditure | EUR 2,975 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2103-1-AE | |
| 2021-03-31 | Expenditure | EUR 351 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2103-1-BR | |
| 2021-03-31 | Expenditure | EUR 4,271 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2103-2-BR-XM-DAC-30010 | |
| 2021-03-31 | Expenditure | EUR 190 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2103-3-BR | |
| 2021-03-31 | Expenditure | EUR 8,822 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2103-1-CD | |
| 2021-03-31 | Expenditure | EUR 1,761 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2103-2-CD | |
| 2021-03-31 | Expenditure | EUR 116k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2103-1-CH | |
| 2021-03-31 | Expenditure | EUR 89k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2103-2-CH-XM-DAC-30010 | |
| 2021-03-31 | Expenditure | EUR 30k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2103-3-CH | |
| 2021-03-31 | Expenditure | EUR 474 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2103-1-CO | |
| 2021-03-31 | Expenditure | EUR 18k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2103-1-FR | |
| 2021-03-31 | Expenditure | EUR 14k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2103-2-FR-XM-DAC-30010 | |
| 2021-03-31 | Expenditure | EUR 455 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2103-1-GB | |
| 2021-03-31 | Expenditure | EUR 18k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2103-2-GB | |
| 2021-03-31 | Expenditure | EUR 8,457 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2103-1-IN | |
| 2021-03-31 | Expenditure | EUR 3,120 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2103-2-IN-GB-GOV-1 | |
| 2021-03-31 | Expenditure | EUR 20k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2103-3-IN-XM-DAC-30010 | |
| 2021-03-31 | Expenditure | EUR 4,610 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2103-1-KE | |
| 2021-03-31 | Expenditure | EUR 4,125 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2103-2-KE-XM-DAC-30010 | |
| 2021-03-31 | Expenditure | EUR 3,734 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2103-1-NL | |
| 2021-03-31 | Expenditure | EUR 3,116 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2103-1-SD | |
| 2021-03-31 | Expenditure | EUR 3,727 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2103-1-US | |
| 2021-03-31 | Expenditure | EUR 26k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2103-2-US-XM-DAC-30010 | |
| 2021-03-31 | Expenditure | EUR 1,414 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2103-3-US | |
| 2021-03-31 | Expenditure | EUR 3,694 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2103-1-ZA | |
| 2021-04-30 | Expenditure | EUR 80k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2104-1-BE | |
| 2021-04-30 | Expenditure | EUR 642 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2104-1-BR | |
| 2021-04-30 | Expenditure | EUR 8,757 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2104-2-BR-XM-DAC-30010 | |
| 2021-04-30 | Expenditure | EUR 49k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2104-1-CD | |
| 2021-04-30 | Expenditure | EUR 290 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2104-2-CD | |
| 2021-04-30 | Expenditure | EUR 94k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2104-1-CH | |
| 2021-04-30 | Expenditure | EUR 886 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2104-2-CH | |
| 2021-04-30 | Expenditure | EUR 70k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2104-3-CH-XM-DAC-30010 | |
| 2021-04-30 | Expenditure | EUR 30k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2104-4-CH | |
| 2021-04-30 | Expenditure | EUR 14k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2104-1-CN | |
| 2021-04-30 | Expenditure | EUR 24k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2104-1-FR | |
| 2021-04-30 | Expenditure | EUR 315 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2104-2-FR | |
| 2021-04-30 | Expenditure | EUR 7,118 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2104-3-FR-XM-DAC-30010 | |
| 2021-04-30 | Expenditure | EUR 35k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2104-1-IN | |
| 2021-04-30 | Expenditure | EUR 1,801 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2104-2-IN | |
| 2021-04-30 | Expenditure | EUR 8,037 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2104-1-KE | |
| 2021-04-30 | Expenditure | EUR 3,792 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2104-2-KE-XM-DAC-30010 | |
| 2021-04-30 | Expenditure | EUR 614 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2104-1-US | |
| 2021-04-30 | Expenditure | EUR 3,061 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2104-2-US-XM-DAC-30010 | |
| 2021-05-31 | Expenditure | EUR 3,641 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2105-1-AU | |
| 2021-05-31 | Expenditure | EUR 784 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2105-1-BR | |
| 2021-05-31 | Expenditure | EUR 11k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2105-2-BR-XM-DAC-30010 | |
| 2021-05-31 | Expenditure | EUR 36k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2105-1-CD | |
| 2021-05-31 | Expenditure | EUR 5,360 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2105-2-CD | |
| 2021-05-31 | Expenditure | EUR 92k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2105-1-CH | |
| 2021-05-31 | Expenditure | EUR 1,273 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2105-2-CH | |
| 2021-05-31 | Expenditure | EUR 74k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2105-3-CH-XM-DAC-30010 | |
| 2021-05-31 | Expenditure | EUR 29k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2105-4-CH | |
| 2021-05-31 | Expenditure | EUR 390 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2105-1-CM | |
| 2021-05-31 | Expenditure | EUR 1,086 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2105-1-CO | |
| 2021-05-31 | Expenditure | EUR 6,017 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2105-1-FR | |
| 2021-05-31 | Expenditure | EUR 17k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2105-2-FR-XM-DAC-30010 | |
| 2021-05-31 | Expenditure | EUR 711 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2105-1-GB | |
| 2021-05-31 | Expenditure | EUR 6,459 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2105-2-GB | |
| 2021-05-31 | Expenditure | EUR 27k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2105-1-IN | |
| 2021-05-31 | Expenditure | EUR 4,772 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2105-1-KE | |
| 2021-05-31 | Expenditure | EUR 5,056 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2105-2-KE-XM-DAC-30010 | |
| 2021-05-31 | Expenditure | EUR 13k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2105-1-TZ-XM-DAC-30010 | |
| 2021-05-31 | Expenditure | EUR 7,371 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2105-1-UG | |
| 2021-05-31 | Expenditure | EUR 2,935 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2105-1-US | |
| 2021-05-31 | Expenditure | EUR 61k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2105-2-US-XM-DAC-30010 | |
| 2021-06-30 | Expenditure | EUR 395 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2106-1-AU | |
| 2021-06-30 | Expenditure | EUR 10k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2106-1-BE | |
| 2021-06-30 | Expenditure | EUR 15k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2106-2-BE | |
| 2021-06-30 | Expenditure | EUR 263k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2106-3-BE-XM-DAC-30010 | |
| 2021-06-30 | Expenditure | EUR 870 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2106-1-BR | |
| 2021-06-30 | Expenditure | EUR 431 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2106-2-BR | |
| 2021-06-30 | Expenditure | EUR 12k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2106-3-BR-XM-DAC-30010 | |
| 2021-06-30 | Expenditure | EUR 53k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2106-1-CD | |
| 2021-06-30 | Expenditure | EUR 9,075 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2106-2-CD | |
| 2021-06-30 | Expenditure | EUR 89k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2106-1-CH | |
| 2021-06-30 | Expenditure | EUR 1,027 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2106-2-CH | |
| 2021-06-30 | Expenditure | EUR 3,610 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2106-3-CH-GB-GOV-1 | |
| 2021-06-30 | Expenditure | EUR 81k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2106-4-CH-XM-DAC-30010 | |
| 2021-06-30 | Expenditure | EUR 29k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2106-5-CH | |
| 2021-06-30 | Expenditure | EUR 44k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2106-1-CI | |
| 2021-06-30 | Expenditure | EUR 19k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2106-1-CM-XM-DAC-30010 | |
| 2021-06-30 | Expenditure | EUR 14k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2106-1-CN | |
| 2021-06-30 | Expenditure | EUR 568 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2106-1-CO | |
| 2021-06-30 | Expenditure | EUR 197k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2106-1-DE | |
| 2021-06-30 | Expenditure | EUR 2,098 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2106-2-DE | |
| 2021-06-30 | Expenditure | EUR 116k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2106-1-ES | |
| 2021-06-30 | Expenditure | EUR 2,331 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2106-2-ES | |
| 2021-06-30 | Expenditure | EUR 288k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2106-3-ES-XM-DAC-30010 | |
| 2021-06-30 | Expenditure | EUR 16k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2106-1-FR | |
| 2021-06-30 | Expenditure | EUR 271k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2106-2-FR-XM-DAC-30010 | |
| 2021-06-30 | Expenditure | EUR 96 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2106-1-GB | |
| 2021-06-30 | Expenditure | EUR 34k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2106-2-GB-XM-DAC-30010 | |
| 2021-06-30 | Expenditure | EUR 8,946 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2106-1-IN | |
| 2021-06-30 | Expenditure | EUR 984 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2106-2-IN | |
| 2021-06-30 | Expenditure | EUR 1,338 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2106-3-IN-GB-GOV-1 | |
| 2021-06-30 | Expenditure | EUR 648 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2106-4-IN-XM-DAC-30010 | |
| 2021-06-30 | Expenditure | EUR 4,653 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2106-1-KE | |
| 2021-06-30 | Expenditure | EUR 5,338 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2106-2-KE-XM-DAC-30010 | |
| 2021-06-30 | Expenditure | EUR 51k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2106-1-SD-XM-DAC-30010 | |
| 2021-06-30 | Expenditure | EUR 3,627 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2106-1-TZ | |
| 2021-06-30 | Expenditure | EUR 9,767 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2106-2-TZ-XM-DAC-30010 | |
| 2021-06-30 | Expenditure | EUR 3,754 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2106-1-US | |
| 2021-06-30 | Expenditure | EUR 4,499 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2106-2-US-XM-DAC-30010 | |
| 2021-07-31 | Expenditure | EUR 5,754 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2107-1-AU | |
| 2021-07-31 | Expenditure | EUR 945 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2107-1-BR | |
| 2021-07-31 | Expenditure | EUR 13k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2107-2-BR-XM-DAC-30010 | |
| 2021-07-31 | Expenditure | EUR 1,116 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2107-3-BR | |
| 2021-07-31 | Expenditure | EUR 23k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2107-1-CD | |
| 2021-07-31 | Expenditure | EUR 20k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2107-2-CD | |
| 2021-07-31 | Expenditure | EUR 1,752 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2107-1-CH | |
| 2021-07-31 | Expenditure | EUR 93k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2107-2-CH | |
| 2021-07-31 | Expenditure | EUR 242 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2107-3-CH | |
| 2021-07-31 | Expenditure | EUR 962 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2107-4-CH-GB-GOV-1 | |
| 2021-07-31 | Expenditure | EUR 145k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2107-5-CH-XM-DAC-30010 | |
| 2021-07-31 | Expenditure | EUR 50k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2107-6-CH | |
| 2021-07-31 | Expenditure | EUR 17k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2107-1-FR | |
| 2021-07-31 | Expenditure | EUR 6,264 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2107-2-FR-XM-DAC-30010 | |
| 2021-07-31 | Expenditure | EUR 1,746 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2107-1-GB | |
| 2021-07-31 | Expenditure | EUR 1,381 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2107-1-IN | |
| 2021-07-31 | Expenditure | EUR 68k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2107-2-IN | |
| 2021-07-31 | Expenditure | EUR 14k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2107-3-IN-GB-GOV-1 | |
| 2021-07-31 | Expenditure | EUR 10k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2107-1-KE | |
| 2021-07-31 | Expenditure | EUR 4,821 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2107-2-KE-XM-DAC-30010 | |
| 2021-07-31 | Expenditure | EUR 64k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2107-1-NL | |
| 2021-07-31 | Expenditure | EUR 4,488 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2107-1-UG | |
| 2021-07-31 | Expenditure | EUR 2,611 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2107-2-UG | |
| 2021-07-31 | Expenditure | EUR 31k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2107-1-US | |
| 2021-07-31 | Expenditure | EUR 61k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2107-2-US-XM-DAC-30010 | |
| 2021-08-31 | Expenditure | EUR 1,332 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2108-1-AU | |
| 2021-08-31 | Expenditure | EUR 728 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2108-1-BR | |
| 2021-08-31 | Expenditure | EUR 14k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2108-2-BR-XM-DAC-30010 | |
| 2021-08-31 | Expenditure | EUR 1,124 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2108-3-BR | |
| 2021-08-31 | Expenditure | EUR 3,709 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2108-1-CD | |
| 2021-08-31 | Expenditure | EUR 18k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2108-2-CD | |
| 2021-08-31 | Expenditure | EUR 91k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2108-1-CH | |
| 2021-08-31 | Expenditure | EUR 244 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2108-2-CH | |
| 2021-08-31 | Expenditure | EUR 5,251 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2108-3-CH-GB-GOV-1 | |
| 2021-08-31 | Expenditure | EUR 70k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2108-4-CH-XM-DAC-30010 | |
| 2021-08-31 | Expenditure | EUR 58k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2108-5-CH | |
| 2021-08-31 | Expenditure | EUR 910 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2108-1-CM | |
| 2021-08-31 | Expenditure | EUR 7,662 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2108-1-CN | |
| 2021-08-31 | Expenditure | EUR 717 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2108-1-CO | |
| 2021-08-31 | Expenditure | EUR 790 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2108-1-FR | |
| 2021-08-31 | Expenditure | EUR 1,612 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2108-2-FR-XM-DAC-30010 | |
| 2021-08-31 | Expenditure | EUR 9,700 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2108-1-GB | |
| 2021-08-31 | Expenditure | EUR 107 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2108-1-IN | |
| 2021-08-31 | Expenditure | EUR 6,363 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2108-2-IN-GB-GOV-1 | |
| 2021-08-31 | Expenditure | EUR 37k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2108-3-IN | |
| 2021-08-31 | Expenditure | EUR 12k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2108-1-KE | |
| 2021-08-31 | Expenditure | EUR 4,955 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2108-2-KE-XM-DAC-30010 | |
| 2021-08-31 | Expenditure | EUR 390 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2108-1-TZ | |
| 2021-08-31 | Expenditure | EUR 27k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2108-1-UG | |
| 2021-08-31 | Expenditure | EUR 8,972 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2108-1-US | |
| 2021-08-31 | Expenditure | EUR 1,746 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2108-2-US | |
| 2021-08-31 | Expenditure | EUR 1,030 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2108-3-US-XM-DAC-30010 | |
| 2021-09-30 | Expenditure | EUR 750 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2109-1-AU | |
| 2021-09-30 | Expenditure | EUR 681 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2109-1-BR | |
| 2021-09-30 | Expenditure | EUR 16k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2109-2-BR-XM-DAC-30010 | |
| 2021-09-30 | Expenditure | EUR 1,130 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2109-3-BR | |
| 2021-09-30 | Expenditure | EUR 5,707 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2109-1-CD | |
| 2021-09-30 | Expenditure | EUR 20k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2109-2-CD | |
| 2021-09-30 | Expenditure | EUR 104k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2109-1-CH | |
| 2021-09-30 | Expenditure | EUR 246 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2109-2-CH | |
| 2021-09-30 | Expenditure | EUR 17k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2109-3-CH-GB-GOV-1 | |
| 2021-09-30 | Expenditure | EUR 60k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2109-4-CH-XM-DAC-30010 | |
| 2021-09-30 | Expenditure | EUR 63k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2109-5-CH | |
| 2021-09-30 | Expenditure | EUR 18k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2109-1-FR | |
| 2021-09-30 | Expenditure | EUR 1,039 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2109-2-FR-XM-DAC-30010 | |
| 2021-09-30 | Expenditure | EUR 78k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2109-1-GB | |
| 2021-09-30 | Expenditure | EUR 46k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2109-1-IN | |
| 2021-09-30 | Expenditure | EUR 7,637 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2109-2-IN-GB-GOV-1 | |
| 2021-09-30 | Expenditure | EUR 57k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2109-3-IN | |
| 2021-09-30 | Expenditure | EUR 10k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2109-1-KE | |
| 2021-09-30 | Expenditure | EUR 4,795 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2109-2-KE-XM-DAC-30010 | |
| 2021-09-30 | Expenditure | EUR 58k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2109-1-NL | |
| 2021-09-30 | Expenditure | EUR 104k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2109-1-US | |
| 2021-09-30 | Expenditure | EUR 54k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2109-2-US-XM-DAC-30010 | |
| 2021-10-31 | Expenditure | EUR 8,808 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2110-1-BR | |
| 2021-10-31 | Expenditure | EUR 5,014 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2110-2-BR-XM-DAC-30010 | |
| 2021-10-31 | Expenditure | EUR 1,313 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2110-3-BR | |
| 2021-10-31 | Expenditure | EUR 31k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2110-1-CD | |
| 2021-10-31 | Expenditure | EUR 6,929 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2110-2-CD | |
| 2021-10-31 | Expenditure | EUR 78k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2110-1-CH | |
| 2021-10-31 | Expenditure | EUR 12k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2110-2-CH | |
| 2021-10-31 | Expenditure | EUR 17k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2110-3-CH-GB-GOV-1 | |
| 2021-10-31 | Expenditure | EUR 52k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2110-4-CH-XM-DAC-30010 | |
| 2021-10-31 | Expenditure | EUR 57k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2110-5-CH | |
| 2021-10-31 | Expenditure | EUR 2,080 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2110-1-CI | |
| 2021-10-31 | Expenditure | EUR 947 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2110-1-CO | |
| 2021-10-31 | Expenditure | EUR 22k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2110-1-FR | |
| 2021-10-31 | Expenditure | EUR 7,258 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2110-2-FR | |
| 2021-10-31 | Expenditure | EUR -11k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2110-3-FR-XM-DAC-30010 | |
| 2021-10-31 | Expenditure | EUR 50k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2110-1-GB | |
| 2021-10-31 | Expenditure | EUR 28k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2110-1-IN | |
| 2021-10-31 | Expenditure | EUR 74k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2110-2-IN-GB-GOV-1 | |
| 2021-10-31 | Expenditure | EUR 70k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2110-3-IN | |
| 2021-10-31 | Expenditure | EUR 13k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2110-1-KE | |
| 2021-10-31 | Expenditure | EUR 4,415 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2110-2-KE-XM-DAC-30010 | |
| 2021-10-31 | Expenditure | EUR 25k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2110-1-KR | |
| 2021-10-31 | Expenditure | EUR 800 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2110-1-UG | |
| 2021-10-31 | Expenditure | EUR 48k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2110-1-US | |
| 2021-10-31 | Expenditure | EUR 1,486 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2110-2-US | |
| 2021-10-31 | Expenditure | EUR 31k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2110-3-US-GB-GOV-1 | |
| 2021-10-31 | Expenditure | EUR 1,034 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2110-4-US-XM-DAC-30010 | |
| 2021-10-31 | Expenditure | EUR 80k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2110-5-US | |
| 2021-11-30 | Expenditure | EUR 15k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2111-1-AU | |
| 2021-11-30 | Expenditure | EUR 72k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2111-1-BE | |
| 2021-11-30 | Expenditure | EUR 325 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2111-1-BR | |
| 2021-11-30 | Expenditure | EUR 4,877 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2111-2-BR-XM-DAC-30010 | |
| 2021-11-30 | Expenditure | EUR 1,277 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2111-3-BR | |
| 2021-11-30 | Expenditure | EUR 73k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2111-1-CD | |
| 2021-11-30 | Expenditure | EUR 12k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2111-2-CD | |
| 2021-11-30 | Expenditure | EUR 81k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2111-1-CH | |
| 2021-11-30 | Expenditure | EUR 13k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2111-2-CH | |
| 2021-11-30 | Expenditure | EUR 18k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2111-3-CH-GB-GOV-1 | |
| 2021-11-30 | Expenditure | EUR 53k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2111-4-CH-XM-DAC-30010 | |
| 2021-11-30 | Expenditure | EUR 66k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2111-5-CH | |
| 2021-11-30 | Expenditure | EUR 40k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2111-1-CN | |
| 2021-11-30 | Expenditure | EUR 856 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2111-1-CO | |
| 2021-11-30 | Expenditure | EUR 13k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2111-1-FR | |
| 2021-11-30 | Expenditure | EUR 2,688 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2111-2-FR | |
| 2021-11-30 | Expenditure | EUR 2,001 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2111-3-FR-XM-DAC-30010 | |
| 2021-11-30 | Expenditure | EUR 20k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2111-4-FR | |
| 2021-11-30 | Expenditure | EUR 64k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2111-1-GB | |
| 2021-11-30 | Expenditure | EUR 32k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2111-1-IL | |
| 2021-11-30 | Expenditure | EUR 15k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2111-1-IN | |
| 2021-11-30 | Expenditure | EUR 7,985 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2111-2-IN-GB-GOV-1 | |
| 2021-11-30 | Expenditure | EUR 12k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2111-1-KE | |
| 2021-11-30 | Expenditure | EUR 3,891 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2111-2-KE-XM-DAC-30010 | |
| 2021-11-30 | Expenditure | EUR 780 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2111-1-TZ | |
| 2021-11-30 | Expenditure | EUR 12k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2111-1-US | |
| 2021-11-30 | Expenditure | EUR 142k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2111-2-US-GB-GOV-1 | |
| 2021-11-30 | Expenditure | EUR 1,569 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2111-3-US-XM-DAC-30010 | |
| 2021-11-30 | Expenditure | EUR 14k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2111-4-US | |
| 2021-12-31 | Expenditure | EUR 38 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2112-1-AR | |
| 2021-12-31 | Expenditure | EUR 6,480 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2112-1-BE | |
| 2021-12-31 | Expenditure | EUR 28k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2112-2-BE | |
| 2021-12-31 | Expenditure | EUR 499k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2112-3-BE-XM-DAC-30010 | |
| 2021-12-31 | Expenditure | EUR 789 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2112-1-BR | |
| 2021-12-31 | Expenditure | EUR 3,401 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2112-2-BR | |
| 2021-12-31 | Expenditure | EUR 9,315 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2112-3-BR-XM-DAC-30010 | |
| 2021-12-31 | Expenditure | EUR 3,989 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2112-4-BR | |
| 2021-12-31 | Expenditure | EUR 28k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2112-1-CA | |
| 2021-12-31 | Expenditure | EUR 958 | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2112-1-CD | |
| 2021-12-31 | Expenditure | EUR 47k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2112-2-CD | |
| 2021-12-31 | Expenditure | EUR 13k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2112-3-CD | |
| 2021-12-31 | Expenditure | EUR 53k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2112-4-CD | |
| 2021-12-31 | Expenditure | EUR 159k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2112-1-CH | |
| 2021-12-31 | Expenditure | EUR 24k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2112-2-CH | |
| 2021-12-31 | Expenditure | EUR 148k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2112-3-CH-GB-GOV-1 | |
| 2021-12-31 | Expenditure | EUR 190k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2112-4-CH-XM-DAC-30010 | |
| 2021-12-31 | Expenditure | EUR 139k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2112-5-CH | |
| 2021-12-31 | Expenditure | EUR 57k | Drugs for Neglected Diseases initiative | Expenses COVID-19 - 81-2112-1-CI |
Showing 300 of 1,242. The API returns all of them.
Struck-through rows were in the previous version, last seen 2026-10-02 02:19 UTC, and are not in the current file.